ShangBay Capital LLC — 2026 Investments
3 investments dated 2026 · listed companies and verified rows first · show all
CURE operates a booking platform that connects pharmacies with delivery service partners to generate online orders.
B2B MarketplacesHealthtechSaaSBerlin, DE
Manuel Aberle(Founder)
Co-investorsAbstract VenturesArtis VenturesJ12 VenturesAccompliceCatalyst Health VenturesCosmic Venture Partners+15 more
Nervonik develops peripheral nerve stimulation (PNS) systems designed for high-motion, dynamic activity, using a patented technology that adds biosensing and objective feedback to neuromodulation.
HardwareHealthtechMedical Devices
Co-investorsFoothill VenturesLumira VenturesUS Venture PartnersAmzak Health
SoundHealth develops FDA 510(k) cleared, drug-free medical devices that use acoustic resonance therapy via forehead bone conduction to treat nasal congestion and improve sleep.
AI & Machine LearningDigital HealthMedical Devices
Co-investorsG Vision CapitalJ4 VenturesMoai CapitalTau Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.